nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—SLC16A1—Methotrexate—psoriasis	0.0862	0.118	CbGbCtD
Salicylic acid—ALB—Acitretin—psoriasis	0.0818	0.112	CbGbCtD
Salicylic acid—PTGS2—Triamcinolone—psoriasis	0.0607	0.0832	CbGbCtD
Salicylic acid—PTGS2—Betamethasone—psoriasis	0.0521	0.0714	CbGbCtD
Salicylic acid—SLC22A11—Methotrexate—psoriasis	0.0445	0.061	CbGbCtD
Salicylic acid—SLC22A7—Methotrexate—psoriasis	0.0424	0.0581	CbGbCtD
Salicylic acid—ALB—Mycophenolate mofetil—psoriasis	0.0383	0.0525	CbGbCtD
Salicylic acid—SLC22A6—Cyclosporine—psoriasis	0.0341	0.0467	CbGbCtD
Salicylic acid—ALB—Prednisone—psoriasis	0.0306	0.042	CbGbCtD
Salicylic acid—PTGS2—Dexamethasone—psoriasis	0.0303	0.0415	CbGbCtD
Salicylic acid—SLC22A8—Methotrexate—psoriasis	0.0259	0.0355	CbGbCtD
Salicylic acid—CYP2C9—Cholecalciferol—psoriasis	0.0238	0.0326	CbGbCtD
Salicylic acid—ABCB1—Mycophenolate mofetil—psoriasis	0.02	0.0275	CbGbCtD
Salicylic acid—SLC22A6—Methotrexate—psoriasis	0.018	0.0247	CbGbCtD
Salicylic acid—ABCB1—Betamethasone—psoriasis	0.0172	0.0236	CbGbCtD
Salicylic acid—ABCB1—Prednisolone—psoriasis	0.017	0.0232	CbGbCtD
Salicylic acid—ABCB1—Hydrocortisone—psoriasis	0.0161	0.022	CbGbCtD
Salicylic acid—ABCB1—Prednisone—psoriasis	0.016	0.0219	CbGbCtD
Salicylic acid—CYP2C9—Cyclosporine—psoriasis	0.0156	0.0214	CbGbCtD
Salicylic acid—ALB—Methotrexate—psoriasis	0.0154	0.0211	CbGbCtD
Salicylic acid—ABCB1—Cyclosporine—psoriasis	0.0152	0.0208	CbGbCtD
Salicylic acid—CYP2C9—Dexamethasone—psoriasis	0.0103	0.0141	CbGbCtD
Salicylic acid—ABCB1—Dexamethasone—psoriasis	0.01	0.0137	CbGbCtD
Salicylic acid—Niacin—HCAR2—psoriasis	0.00914	0.708	CrCbGaD
Salicylic acid—ABCB1—Methotrexate—psoriasis	0.00803	0.011	CbGbCtD
Salicylic acid—Acetylsalicylic acid—NFKBIA—psoriasis	0.00224	0.174	CrCbGaD
Salicylic acid—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.00103	0.157	CbGdCrCtD
Salicylic acid—Acetylsalicylic acid—TP53—psoriasis	0.000992	0.0769	CrCbGaD
Salicylic acid—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.000822	0.126	CbGdCrCtD
Salicylic acid—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000798	0.122	CbGdCrCtD
Salicylic acid—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000619	0.0949	CbGdCrCtD
Salicylic acid—Mesalazine—PPARG—psoriasis	0.000534	0.0414	CrCbGaD
Salicylic acid—Pruritus—Methoxsalen—psoriasis	0.000514	0.00216	CcSEcCtD
Salicylic acid—Ecchymosis—Prednisone—psoriasis	0.000514	0.00215	CcSEcCtD
Salicylic acid—Somnolence—Acitretin—psoriasis	0.000513	0.00215	CcSEcCtD
Salicylic acid—Dyspepsia—Acitretin—psoriasis	0.000507	0.00213	CcSEcCtD
Salicylic acid—Abdominal pain upper—Hydrocortisone—psoriasis	0.000506	0.00212	CcSEcCtD
Salicylic acid—Decreased appetite—Acitretin—psoriasis	0.000501	0.0021	CcSEcCtD
Salicylic acid—Tinnitus—Mycophenolic acid—psoriasis	0.000497	0.00209	CcSEcCtD
Salicylic acid—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.000496	0.076	CbGdCrCtD
Salicylic acid—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.000496	0.076	CbGdCrCtD
Salicylic acid—Pain—Acitretin—psoriasis	0.000493	0.00207	CcSEcCtD
Salicylic acid—Constipation—Acitretin—psoriasis	0.000493	0.00207	CcSEcCtD
Salicylic acid—Pain—Fluocinolone Acetonide—psoriasis	0.000492	0.00206	CcSEcCtD
Salicylic acid—Weight increased—Cyclosporine—psoriasis	0.000491	0.00206	CcSEcCtD
Salicylic acid—Lethargy—Betamethasone—psoriasis	0.000483	0.00203	CcSEcCtD
Salicylic acid—Lethargy—Dexamethasone—psoriasis	0.000483	0.00203	CcSEcCtD
Salicylic acid—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000482	0.0738	CbGdCrCtD
Salicylic acid—Dizziness—Methoxsalen—psoriasis	0.000481	0.00202	CcSEcCtD
Salicylic acid—Weight increased—Mycophenolate mofetil—psoriasis	0.000479	0.00201	CcSEcCtD
Salicylic acid—Feeling abnormal—Acitretin—psoriasis	0.000475	0.00199	CcSEcCtD
Salicylic acid—Pruritus—Calcitriol—psoriasis	0.000458	0.00192	CcSEcCtD
Salicylic acid—Rash—Methoxsalen—psoriasis	0.000458	0.00192	CcSEcCtD
Salicylic acid—Dermatitis—Methoxsalen—psoriasis	0.000458	0.00192	CcSEcCtD
Salicylic acid—Urticaria—Acitretin—psoriasis	0.000458	0.00192	CcSEcCtD
Salicylic acid—Headache—Methoxsalen—psoriasis	0.000455	0.00191	CcSEcCtD
Salicylic acid—Epistaxis—Cyclosporine—psoriasis	0.000454	0.0019	CcSEcCtD
Salicylic acid—Skin exfoliation—Methotrexate—psoriasis	0.000454	0.0019	CcSEcCtD
Salicylic acid—Oedema—Hydroxyurea—psoriasis	0.000453	0.0019	CcSEcCtD
Salicylic acid—Asthma—Triamcinolone—psoriasis	0.000451	0.00189	CcSEcCtD
Salicylic acid—Weight increased—Prednisolone—psoriasis	0.000447	0.00187	CcSEcCtD
Salicylic acid—Diarrhoea—Calcitriol—psoriasis	0.000443	0.00186	CcSEcCtD
Salicylic acid—Epistaxis—Mycophenolate mofetil—psoriasis	0.000442	0.00186	CcSEcCtD
Salicylic acid—Weight increased—Hydrocortisone—psoriasis	0.000436	0.00183	CcSEcCtD
Salicylic acid—Nausea—Methoxsalen—psoriasis	0.000432	0.00181	CcSEcCtD
Salicylic acid—Hepatitis—Cyclosporine—psoriasis	0.000432	0.00181	CcSEcCtD
Salicylic acid—Anorexia—Hydroxyurea—psoriasis	0.000431	0.00181	CcSEcCtD
Salicylic acid—Ecchymosis—Methotrexate—psoriasis	0.000429	0.0018	CcSEcCtD
Salicylic acid—Hepatitis—Mycophenolate mofetil—psoriasis	0.000421	0.00177	CcSEcCtD
Salicylic acid—Lethargy—Prednisone—psoriasis	0.000421	0.00177	CcSEcCtD
Salicylic acid—Hallucination—Mycophenolate mofetil—psoriasis	0.000419	0.00176	CcSEcCtD
Salicylic acid—Vomiting—Calcitriol—psoriasis	0.000412	0.00173	CcSEcCtD
Salicylic acid—Weight increased—Triamcinolone—psoriasis	0.000411	0.00172	CcSEcCtD
Salicylic acid—Rash—Calcitriol—psoriasis	0.000409	0.00171	CcSEcCtD
Salicylic acid—Dermatitis—Calcitriol—psoriasis	0.000408	0.00171	CcSEcCtD
Salicylic acid—Pruritus—Acitretin—psoriasis	0.000408	0.00171	CcSEcCtD
Salicylic acid—Pruritus—Fluocinolone Acetonide—psoriasis	0.000407	0.00171	CcSEcCtD
Salicylic acid—Headache—Calcitriol—psoriasis	0.000406	0.0017	CcSEcCtD
Salicylic acid—Tinnitus—Cyclosporine—psoriasis	0.000402	0.00169	CcSEcCtD
Salicylic acid—Somnolence—Hydroxyurea—psoriasis	0.000402	0.00169	CcSEcCtD
Salicylic acid—Dyspepsia—Hydroxyurea—psoriasis	0.000398	0.00167	CcSEcCtD
Salicylic acid—Diarrhoea—Acitretin—psoriasis	0.000394	0.00165	CcSEcCtD
Salicylic acid—Decreased appetite—Hydroxyurea—psoriasis	0.000393	0.00165	CcSEcCtD
Salicylic acid—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000393	0.00165	CcSEcCtD
Salicylic acid—Tinnitus—Mycophenolate mofetil—psoriasis	0.000393	0.00165	CcSEcCtD
Salicylic acid—Constipation—Hydroxyurea—psoriasis	0.000387	0.00162	CcSEcCtD
Salicylic acid—Pain—Hydroxyurea—psoriasis	0.000387	0.00162	CcSEcCtD
Salicylic acid—Nausea—Calcitriol—psoriasis	0.000385	0.00161	CcSEcCtD
Salicylic acid—Confusional state—Mycophenolic acid—psoriasis	0.000382	0.0016	CcSEcCtD
Salicylic acid—Hallucination—Hydrocortisone—psoriasis	0.000382	0.0016	CcSEcCtD
Salicylic acid—Dizziness—Acitretin—psoriasis	0.000381	0.0016	CcSEcCtD
Salicylic acid—Dizziness—Fluocinolone Acetonide—psoriasis	0.00038	0.00159	CcSEcCtD
Salicylic acid—Epistaxis—Triamcinolone—psoriasis	0.00038	0.00159	CcSEcCtD
Salicylic acid—Oedema—Mycophenolic acid—psoriasis	0.000379	0.00159	CcSEcCtD
Salicylic acid—PTGS2—Fluocinonide—Dexamethasone—psoriasis	0.000374	0.0574	CbGdCrCtD
Salicylic acid—PTGS2—Fluocinonide—Betamethasone—psoriasis	0.000374	0.0574	CbGdCrCtD
Salicylic acid—Feeling abnormal—Hydroxyurea—psoriasis	0.000373	0.00156	CcSEcCtD
Salicylic acid—Weight increased—Dexamethasone—psoriasis	0.000373	0.00156	CcSEcCtD
Salicylic acid—Weight increased—Betamethasone—psoriasis	0.000373	0.00156	CcSEcCtD
Salicylic acid—Dysgeusia—Cyclosporine—psoriasis	0.000368	0.00154	CcSEcCtD
Salicylic acid—Vomiting—Acitretin—psoriasis	0.000367	0.00154	CcSEcCtD
Salicylic acid—PTGS2—Fluocinonide—Triamcinolone—psoriasis	0.000366	0.0561	CbGdCrCtD
Salicylic acid—Vomiting—Fluocinolone Acetonide—psoriasis	0.000366	0.00153	CcSEcCtD
Salicylic acid—Rash—Acitretin—psoriasis	0.000363	0.00152	CcSEcCtD
Salicylic acid—Dermatitis—Acitretin—psoriasis	0.000363	0.00152	CcSEcCtD
Salicylic acid—Rash—Fluocinolone Acetonide—psoriasis	0.000362	0.00152	CcSEcCtD
Salicylic acid—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000362	0.00152	CcSEcCtD
Salicylic acid—Anorexia—Mycophenolic acid—psoriasis	0.000361	0.00152	CcSEcCtD
Salicylic acid—Headache—Acitretin—psoriasis	0.000361	0.00151	CcSEcCtD
Salicylic acid—Headache—Fluocinolone Acetonide—psoriasis	0.00036	0.00151	CcSEcCtD
Salicylic acid—Dysgeusia—Mycophenolate mofetil—psoriasis	0.000359	0.00151	CcSEcCtD
Salicylic acid—Lethargy—Methotrexate—psoriasis	0.000352	0.00148	CcSEcCtD
Salicylic acid—Nausea—Acitretin—psoriasis	0.000342	0.00144	CcSEcCtD
Salicylic acid—Erythema—Prednisolone—psoriasis	0.000342	0.00143	CcSEcCtD
Salicylic acid—Nausea—Fluocinolone Acetonide—psoriasis	0.000341	0.00143	CcSEcCtD
Salicylic acid—Somnolence—Mycophenolic acid—psoriasis	0.000337	0.00141	CcSEcCtD
Salicylic acid—Erythema—Hydrocortisone—psoriasis	0.000334	0.0014	CcSEcCtD
Salicylic acid—Dyspepsia—Mycophenolic acid—psoriasis	0.000334	0.0014	CcSEcCtD
Salicylic acid—Decreased appetite—Mycophenolic acid—psoriasis	0.00033	0.00138	CcSEcCtD
Salicylic acid—Hallucination—Dexamethasone—psoriasis	0.000326	0.00137	CcSEcCtD
Salicylic acid—Hallucination—Betamethasone—psoriasis	0.000326	0.00137	CcSEcCtD
Salicylic acid—Weight increased—Prednisone—psoriasis	0.000325	0.00136	CcSEcCtD
Salicylic acid—Constipation—Mycophenolic acid—psoriasis	0.000324	0.00136	CcSEcCtD
Salicylic acid—Pain—Mycophenolic acid—psoriasis	0.000324	0.00136	CcSEcCtD
Salicylic acid—Erythema—Triamcinolone—psoriasis	0.000314	0.00132	CcSEcCtD
Salicylic acid—Feeling abnormal—Mycophenolic acid—psoriasis	0.000312	0.00131	CcSEcCtD
Salicylic acid—Diarrhoea—Hydroxyurea—psoriasis	0.00031	0.0013	CcSEcCtD
Salicylic acid—Confusional state—Cyclosporine—psoriasis	0.000309	0.0013	CcSEcCtD
Salicylic acid—Dysgeusia—Triamcinolone—psoriasis	0.000308	0.00129	CcSEcCtD
Salicylic acid—Oedema—Cyclosporine—psoriasis	0.000307	0.00129	CcSEcCtD
Salicylic acid—Confusional state—Mycophenolate mofetil—psoriasis	0.000302	0.00126	CcSEcCtD
Salicylic acid—Dizziness—Hydroxyurea—psoriasis	0.000299	0.00126	CcSEcCtD
Salicylic acid—Oedema—Mycophenolate mofetil—psoriasis	0.000299	0.00125	CcSEcCtD
Salicylic acid—Asthma—Methotrexate—psoriasis	0.000298	0.00125	CcSEcCtD
Salicylic acid—Anorexia—Cyclosporine—psoriasis	0.000292	0.00123	CcSEcCtD
Salicylic acid—Vomiting—Hydroxyurea—psoriasis	0.000288	0.00121	CcSEcCtD
Salicylic acid—Abdominal discomfort—Methotrexate—psoriasis	0.000286	0.0012	CcSEcCtD
Salicylic acid—Rash—Hydroxyurea—psoriasis	0.000285	0.0012	CcSEcCtD
Salicylic acid—Erythema—Betamethasone—psoriasis	0.000285	0.0012	CcSEcCtD
Salicylic acid—Erythema—Dexamethasone—psoriasis	0.000285	0.0012	CcSEcCtD
Salicylic acid—Anorexia—Mycophenolate mofetil—psoriasis	0.000285	0.0012	CcSEcCtD
Salicylic acid—Dermatitis—Hydroxyurea—psoriasis	0.000285	0.0012	CcSEcCtD
Salicylic acid—Hallucination—Prednisone—psoriasis	0.000284	0.00119	CcSEcCtD
Salicylic acid—Headache—Hydroxyurea—psoriasis	0.000284	0.00119	CcSEcCtD
Salicylic acid—Oedema—Prednisolone—psoriasis	0.000279	0.00117	CcSEcCtD
Salicylic acid—Somnolence—Cyclosporine—psoriasis	0.000273	0.00114	CcSEcCtD
Salicylic acid—Oedema—Hydrocortisone—psoriasis	0.000273	0.00114	CcSEcCtD
Salicylic acid—Dyspepsia—Cyclosporine—psoriasis	0.00027	0.00113	CcSEcCtD
Salicylic acid—Nausea—Hydroxyurea—psoriasis	0.000269	0.00113	CcSEcCtD
Salicylic acid—Pruritus—Mycophenolic acid—psoriasis	0.000268	0.00112	CcSEcCtD
Salicylic acid—Decreased appetite—Cyclosporine—psoriasis	0.000267	0.00112	CcSEcCtD
Salicylic acid—Somnolence—Mycophenolate mofetil—psoriasis	0.000266	0.00112	CcSEcCtD
Salicylic acid—Drowsiness—Methotrexate—psoriasis	0.000266	0.00111	CcSEcCtD
Salicylic acid—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000263	0.0011	CcSEcCtD
Salicylic acid—Pain—Cyclosporine—psoriasis	0.000262	0.0011	CcSEcCtD
Salicylic acid—Constipation—Cyclosporine—psoriasis	0.000262	0.0011	CcSEcCtD
Salicylic acid—Decreased appetite—Mycophenolate mofetil—psoriasis	0.00026	0.00109	CcSEcCtD
Salicylic acid—Anorexia—Hydrocortisone—psoriasis	0.00026	0.00109	CcSEcCtD
Salicylic acid—Diarrhoea—Mycophenolic acid—psoriasis	0.000259	0.00109	CcSEcCtD
Salicylic acid—Oedema—Triamcinolone—psoriasis	0.000257	0.00108	CcSEcCtD
Salicylic acid—Constipation—Mycophenolate mofetil—psoriasis	0.000256	0.00107	CcSEcCtD
Salicylic acid—Pain—Mycophenolate mofetil—psoriasis	0.000256	0.00107	CcSEcCtD
Salicylic acid—Feeling abnormal—Cyclosporine—psoriasis	0.000253	0.00106	CcSEcCtD
Salicylic acid—Dizziness—Mycophenolic acid—psoriasis	0.000251	0.00105	CcSEcCtD
Salicylic acid—Epistaxis—Methotrexate—psoriasis	0.000251	0.00105	CcSEcCtD
Salicylic acid—Erythema—Prednisone—psoriasis	0.000248	0.00104	CcSEcCtD
Salicylic acid—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000247	0.00103	CcSEcCtD
Salicylic acid—Urticaria—Cyclosporine—psoriasis	0.000244	0.00102	CcSEcCtD
Salicylic acid—Vomiting—Mycophenolic acid—psoriasis	0.000241	0.00101	CcSEcCtD
Salicylic acid—Dyspepsia—Hydrocortisone—psoriasis	0.00024	0.00101	CcSEcCtD
Salicylic acid—Rash—Mycophenolic acid—psoriasis	0.000239	0.001	CcSEcCtD
Salicylic acid—Dermatitis—Mycophenolic acid—psoriasis	0.000239	0.001	CcSEcCtD
Salicylic acid—Pain—Prednisolone—psoriasis	0.000239	0.001	CcSEcCtD
Salicylic acid—Hepatitis—Methotrexate—psoriasis	0.000239	0.001	CcSEcCtD
Salicylic acid—Urticaria—Mycophenolate mofetil—psoriasis	0.000238	0.000997	CcSEcCtD
Salicylic acid—Headache—Mycophenolic acid—psoriasis	0.000237	0.000996	CcSEcCtD
Salicylic acid—Decreased appetite—Hydrocortisone—psoriasis	0.000237	0.000994	CcSEcCtD
Salicylic acid—Pain—Hydrocortisone—psoriasis	0.000233	0.000977	CcSEcCtD
Salicylic acid—Oedema—Dexamethasone—psoriasis	0.000233	0.000976	CcSEcCtD
Salicylic acid—Oedema—Betamethasone—psoriasis	0.000233	0.000976	CcSEcCtD
Salicylic acid—Feeling abnormal—Prednisolone—psoriasis	0.00023	0.000964	CcSEcCtD
Salicylic acid—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	0.000226	0.0346	CbGdCrCtD
Salicylic acid—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	0.000226	0.0346	CbGdCrCtD
Salicylic acid—Dyspepsia—Triamcinolone—psoriasis	0.000226	0.000947	CcSEcCtD
Salicylic acid—Erythema multiforme—Methotrexate—psoriasis	0.000226	0.000946	CcSEcCtD
Salicylic acid—Nausea—Mycophenolic acid—psoriasis	0.000225	0.000944	CcSEcCtD
Salicylic acid—Feeling abnormal—Hydrocortisone—psoriasis	0.000225	0.000942	CcSEcCtD
Salicylic acid—Tinnitus—Methotrexate—psoriasis	0.000222	0.000933	CcSEcCtD
Salicylic acid—Anorexia—Betamethasone—psoriasis	0.000222	0.000931	CcSEcCtD
Salicylic acid—Anorexia—Dexamethasone—psoriasis	0.000222	0.000931	CcSEcCtD
Salicylic acid—Urticaria—Prednisolone—psoriasis	0.000222	0.00093	CcSEcCtD
Salicylic acid—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	0.000221	0.0338	CbGdCrCtD
Salicylic acid—Pain—Triamcinolone—psoriasis	0.000219	0.00092	CcSEcCtD
Salicylic acid—Pruritus—Cyclosporine—psoriasis	0.000217	0.00091	CcSEcCtD
Salicylic acid—Urticaria—Hydrocortisone—psoriasis	0.000217	0.000908	CcSEcCtD
Salicylic acid—Pruritus—Mycophenolate mofetil—psoriasis	0.000212	0.000888	CcSEcCtD
Salicylic acid—Feeling abnormal—Triamcinolone—psoriasis	0.000211	0.000887	CcSEcCtD
Salicylic acid—Diarrhoea—Cyclosporine—psoriasis	0.00021	0.00088	CcSEcCtD
Salicylic acid—Erythema—Methotrexate—psoriasis	0.000208	0.000871	CcSEcCtD
Salicylic acid—Dyspepsia—Betamethasone—psoriasis	0.000205	0.00086	CcSEcCtD
Salicylic acid—Dyspepsia—Dexamethasone—psoriasis	0.000205	0.00086	CcSEcCtD
Salicylic acid—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000205	0.000858	CcSEcCtD
Salicylic acid—Urticaria—Triamcinolone—psoriasis	0.000204	0.000855	CcSEcCtD
Salicylic acid—Dysgeusia—Methotrexate—psoriasis	0.000203	0.000853	CcSEcCtD
Salicylic acid—Dizziness—Cyclosporine—psoriasis	0.000203	0.00085	CcSEcCtD
Salicylic acid—Oedema—Prednisone—psoriasis	0.000203	0.00085	CcSEcCtD
Salicylic acid—Decreased appetite—Betamethasone—psoriasis	0.000202	0.000849	CcSEcCtD
Salicylic acid—Decreased appetite—Dexamethasone—psoriasis	0.000202	0.000849	CcSEcCtD
Salicylic acid—Pain—Betamethasone—psoriasis	0.000199	0.000835	CcSEcCtD
Salicylic acid—Pain—Dexamethasone—psoriasis	0.000199	0.000835	CcSEcCtD
Salicylic acid—Dizziness—Mycophenolate mofetil—psoriasis	0.000198	0.00083	CcSEcCtD
Salicylic acid—Vomiting—Cyclosporine—psoriasis	0.000195	0.000818	CcSEcCtD
Salicylic acid—Rash—Cyclosporine—psoriasis	0.000193	0.000811	CcSEcCtD
Salicylic acid—Anorexia—Prednisone—psoriasis	0.000193	0.000811	CcSEcCtD
Salicylic acid—Dermatitis—Cyclosporine—psoriasis	0.000193	0.00081	CcSEcCtD
Salicylic acid—Pruritus—Hydrocortisone—psoriasis	0.000193	0.000809	CcSEcCtD
Salicylic acid—Headache—Cyclosporine—psoriasis	0.000192	0.000806	CcSEcCtD
Salicylic acid—Feeling abnormal—Dexamethasone—psoriasis	0.000192	0.000805	CcSEcCtD
Salicylic acid—Feeling abnormal—Betamethasone—psoriasis	0.000192	0.000805	CcSEcCtD
Salicylic acid—Vomiting—Mycophenolate mofetil—psoriasis	0.00019	0.000798	CcSEcCtD
Salicylic acid—Rash—Mycophenolate mofetil—psoriasis	0.000189	0.000791	CcSEcCtD
Salicylic acid—Dermatitis—Mycophenolate mofetil—psoriasis	0.000188	0.00079	CcSEcCtD
Salicylic acid—Headache—Mycophenolate mofetil—psoriasis	0.000187	0.000786	CcSEcCtD
Salicylic acid—Diarrhoea—Hydrocortisone—psoriasis	0.000186	0.000782	CcSEcCtD
Salicylic acid—Urticaria—Dexamethasone—psoriasis	0.000185	0.000776	CcSEcCtD
Salicylic acid—Urticaria—Betamethasone—psoriasis	0.000185	0.000776	CcSEcCtD
Salicylic acid—Dizziness—Prednisolone—psoriasis	0.000185	0.000774	CcSEcCtD
Salicylic acid—Nausea—Cyclosporine—psoriasis	0.000182	0.000764	CcSEcCtD
Salicylic acid—Pruritus—Triamcinolone—psoriasis	0.000182	0.000761	CcSEcCtD
Salicylic acid—Dizziness—Hydrocortisone—psoriasis	0.00018	0.000756	CcSEcCtD
Salicylic acid—Dyspepsia—Prednisone—psoriasis	0.000179	0.000749	CcSEcCtD
Salicylic acid—Nausea—Mycophenolate mofetil—psoriasis	0.000178	0.000745	CcSEcCtD
Salicylic acid—Decreased appetite—Prednisone—psoriasis	0.000176	0.000739	CcSEcCtD
Salicylic acid—Rash—Prednisolone—psoriasis	0.000176	0.000738	CcSEcCtD
Salicylic acid—Dermatitis—Prednisolone—psoriasis	0.000176	0.000737	CcSEcCtD
Salicylic acid—Headache—Prednisolone—psoriasis	0.000175	0.000733	CcSEcCtD
Salicylic acid—PTGS1—Overview of nanoparticle effects—CRP—psoriasis	0.000174	0.0139	CbGpPWpGaD
Salicylic acid—Constipation—Prednisone—psoriasis	0.000173	0.000727	CcSEcCtD
Salicylic acid—Vomiting—Hydrocortisone—psoriasis	0.000173	0.000727	CcSEcCtD
Salicylic acid—Rash—Hydrocortisone—psoriasis	0.000172	0.000721	CcSEcCtD
Salicylic acid—Dermatitis—Hydrocortisone—psoriasis	0.000172	0.00072	CcSEcCtD
Salicylic acid—Confusional state—Methotrexate—psoriasis	0.000171	0.000717	CcSEcCtD
Salicylic acid—Headache—Hydrocortisone—psoriasis	0.000171	0.000716	CcSEcCtD
Salicylic acid—Dizziness—Triamcinolone—psoriasis	0.00017	0.000712	CcSEcCtD
Salicylic acid—Feeling abnormal—Prednisone—psoriasis	0.000167	0.000701	CcSEcCtD
Salicylic acid—Nausea—Prednisolone—psoriasis	0.000166	0.000695	CcSEcCtD
Salicylic acid—Pruritus—Dexamethasone—psoriasis	0.000165	0.000691	CcSEcCtD
Salicylic acid—Pruritus—Betamethasone—psoriasis	0.000165	0.000691	CcSEcCtD
Salicylic acid—Vomiting—Triamcinolone—psoriasis	0.000163	0.000684	CcSEcCtD
Salicylic acid—Nausea—Hydrocortisone—psoriasis	0.000162	0.000679	CcSEcCtD
Salicylic acid—Rash—Triamcinolone—psoriasis	0.000162	0.000679	CcSEcCtD
Salicylic acid—Dermatitis—Triamcinolone—psoriasis	0.000162	0.000678	CcSEcCtD
Salicylic acid—Anorexia—Methotrexate—psoriasis	0.000162	0.000677	CcSEcCtD
Salicylic acid—Urticaria—Prednisone—psoriasis	0.000161	0.000676	CcSEcCtD
Salicylic acid—AKR1C1—Diseases associated with visual transduction—APOE—psoriasis	0.000161	0.0128	CbGpPWpGaD
Salicylic acid—Headache—Triamcinolone—psoriasis	0.000161	0.000674	CcSEcCtD
Salicylic acid—Diarrhoea—Betamethasone—psoriasis	0.000159	0.000668	CcSEcCtD
Salicylic acid—Diarrhoea—Dexamethasone—psoriasis	0.000159	0.000668	CcSEcCtD
Salicylic acid—Dizziness—Dexamethasone—psoriasis	0.000154	0.000646	CcSEcCtD
Salicylic acid—Dizziness—Betamethasone—psoriasis	0.000154	0.000646	CcSEcCtD
Salicylic acid—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000153	0.0122	CbGpPWpGaD
Salicylic acid—Nausea—Triamcinolone—psoriasis	0.000152	0.000639	CcSEcCtD
Salicylic acid—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000151	0.0121	CbGpPWpGaD
Salicylic acid—Somnolence—Methotrexate—psoriasis	0.000151	0.000632	CcSEcCtD
Salicylic acid—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.00015	0.012	CbGpPWpGaD
Salicylic acid—Dyspepsia—Methotrexate—psoriasis	0.000149	0.000626	CcSEcCtD
Salicylic acid—Vomiting—Dexamethasone—psoriasis	0.000148	0.000621	CcSEcCtD
Salicylic acid—Vomiting—Betamethasone—psoriasis	0.000148	0.000621	CcSEcCtD
Salicylic acid—Decreased appetite—Methotrexate—psoriasis	0.000147	0.000618	CcSEcCtD
Salicylic acid—Rash—Dexamethasone—psoriasis	0.000147	0.000616	CcSEcCtD
Salicylic acid—Rash—Betamethasone—psoriasis	0.000147	0.000616	CcSEcCtD
Salicylic acid—Dermatitis—Dexamethasone—psoriasis	0.000147	0.000615	CcSEcCtD
Salicylic acid—Dermatitis—Betamethasone—psoriasis	0.000147	0.000615	CcSEcCtD
Salicylic acid—Headache—Betamethasone—psoriasis	0.000146	0.000612	CcSEcCtD
Salicylic acid—Headache—Dexamethasone—psoriasis	0.000146	0.000612	CcSEcCtD
Salicylic acid—Pain—Methotrexate—psoriasis	0.000145	0.000608	CcSEcCtD
Salicylic acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.000145	0.0116	CbGpPWpGaD
Salicylic acid—Pruritus—Prednisone—psoriasis	0.000143	0.000602	CcSEcCtD
Salicylic acid—Feeling abnormal—Methotrexate—psoriasis	0.00014	0.000586	CcSEcCtD
Salicylic acid—Diarrhoea—Prednisone—psoriasis	0.000139	0.000582	CcSEcCtD
Salicylic acid—PTGS2—Overview of nanoparticle effects—CRP—psoriasis	0.000138	0.0111	CbGpPWpGaD
Salicylic acid—Nausea—Dexamethasone—psoriasis	0.000138	0.00058	CcSEcCtD
Salicylic acid—Nausea—Betamethasone—psoriasis	0.000138	0.00058	CcSEcCtD
Salicylic acid—Urticaria—Methotrexate—psoriasis	0.000135	0.000565	CcSEcCtD
Salicylic acid—Dizziness—Prednisone—psoriasis	0.000134	0.000562	CcSEcCtD
Salicylic acid—ALB—HDL-mediated lipid transport—APOE—psoriasis	0.000132	0.0106	CbGpPWpGaD
Salicylic acid—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000131	0.0105	CbGpPWpGaD
Salicylic acid—Vomiting—Prednisone—psoriasis	0.000129	0.000541	CcSEcCtD
Salicylic acid—Rash—Prednisone—psoriasis	0.000128	0.000536	CcSEcCtD
Salicylic acid—Dermatitis—Prednisone—psoriasis	0.000128	0.000536	CcSEcCtD
Salicylic acid—Headache—Prednisone—psoriasis	0.000127	0.000533	CcSEcCtD
Salicylic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000126	0.01	CbGpPWpGaD
Salicylic acid—PTGS1—Biological oxidations—CYP2S1—psoriasis	0.000126	0.01	CbGpPWpGaD
Salicylic acid—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000124	0.00991	CbGpPWpGaD
Salicylic acid—Nausea—Prednisone—psoriasis	0.00012	0.000505	CcSEcCtD
Salicylic acid—Pruritus—Methotrexate—psoriasis	0.00012	0.000503	CcSEcCtD
Salicylic acid—Diarrhoea—Methotrexate—psoriasis	0.000116	0.000486	CcSEcCtD
Salicylic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—psoriasis	0.000114	0.00912	CbGpPWpGaD
Salicylic acid—PTGS1—Overview of nanoparticle effects—CXCL8—psoriasis	0.000113	0.00905	CbGpPWpGaD
Salicylic acid—Dizziness—Methotrexate—psoriasis	0.000112	0.00047	CcSEcCtD
Salicylic acid—Vomiting—Methotrexate—psoriasis	0.000108	0.000452	CcSEcCtD
Salicylic acid—Rash—Methotrexate—psoriasis	0.000107	0.000448	CcSEcCtD
Salicylic acid—Dermatitis—Methotrexate—psoriasis	0.000107	0.000448	CcSEcCtD
Salicylic acid—Headache—Methotrexate—psoriasis	0.000106	0.000445	CcSEcCtD
Salicylic acid—Nausea—Methotrexate—psoriasis	0.000101	0.000422	CcSEcCtD
Salicylic acid—SLCO2B1—SLC-mediated transmembrane transport—CP—psoriasis	9.89e-05	0.0079	CbGpPWpGaD
Salicylic acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	9.61e-05	0.00767	CbGpPWpGaD
Salicylic acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	9.25e-05	0.00738	CbGpPWpGaD
Salicylic acid—PTGS2—Overview of nanoparticle effects—CXCL8—psoriasis	9.01e-05	0.00719	CbGpPWpGaD
Salicylic acid—SLC22A11—SLC-mediated transmembrane transport—CP—psoriasis	8.96e-05	0.00715	CbGpPWpGaD
Salicylic acid—SLC16A1—SLC-mediated transmembrane transport—CP—psoriasis	8.79e-05	0.00701	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—NDUFA5—psoriasis	8.62e-05	0.00688	CbGpPWpGaD
Salicylic acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	8.39e-05	0.0067	CbGpPWpGaD
Salicylic acid—SLC22A7—SLC-mediated transmembrane transport—CP—psoriasis	8.13e-05	0.00649	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.04e-05	0.00641	CbGpPWpGaD
Salicylic acid—PTGS1—Overview of nanoparticle effects—TNF—psoriasis	7.9e-05	0.0063	CbGpPWpGaD
Salicylic acid—SLC22A7—Fluoropyrimidine Activity—TP53—psoriasis	7.89e-05	0.00629	CbGpPWpGaD
Salicylic acid—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	7.78e-05	0.00621	CbGpPWpGaD
Salicylic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	7.75e-05	0.00618	CbGpPWpGaD
Salicylic acid—ALB—Lipoprotein metabolism—APOE—psoriasis	7.61e-05	0.00607	CbGpPWpGaD
Salicylic acid—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.54e-05	0.00601	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—psoriasis	7.39e-05	0.0059	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—CYP2S1—psoriasis	7.33e-05	0.00585	CbGpPWpGaD
Salicylic acid—PTGS2—S1P1 pathway—VEGFA—psoriasis	7.32e-05	0.00584	CbGpPWpGaD
Salicylic acid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.04e-05	0.00562	CbGpPWpGaD
Salicylic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—psoriasis	6.91e-05	0.00551	CbGpPWpGaD
Salicylic acid—SLC22A8—SLC-mediated transmembrane transport—CP—psoriasis	6.84e-05	0.00546	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—HCAR2—psoriasis	6.78e-05	0.00541	CbGpPWpGaD
Salicylic acid—CYP2C9—Biological oxidations—CYP2S1—psoriasis	6.6e-05	0.00527	CbGpPWpGaD
Salicylic acid—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	6.51e-05	0.00519	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—CAT—psoriasis	6.45e-05	0.00514	CbGpPWpGaD
Salicylic acid—PTGS1—Overview of nanoparticle effects—IL6—psoriasis	6.37e-05	0.00509	CbGpPWpGaD
Salicylic acid—PTGS2—Overview of nanoparticle effects—TNF—psoriasis	6.27e-05	0.005	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—SERPINB8—psoriasis	6.21e-05	0.00495	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—HLA-C—psoriasis	6.01e-05	0.00479	CbGpPWpGaD
Salicylic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—psoriasis	5.97e-05	0.00476	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL13—psoriasis	5.97e-05	0.00476	CbGpPWpGaD
Salicylic acid—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	5.93e-05	0.00473	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TAGAP—psoriasis	5.88e-05	0.00469	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	5.82e-05	0.00464	CbGpPWpGaD
Salicylic acid—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	5.71e-05	0.00455	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL17A—psoriasis	5.49e-05	0.00438	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—psoriasis	5.44e-05	0.00434	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—ITGAL—psoriasis	5.34e-05	0.00426	CbGpPWpGaD
Salicylic acid—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.25e-05	0.00419	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—CAT—psoriasis	5.21e-05	0.00416	CbGpPWpGaD
Salicylic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	5.14e-05	0.0041	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—CRP—psoriasis	5.12e-05	0.00408	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—CAT—psoriasis	5.12e-05	0.00408	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL12B—psoriasis	5.11e-05	0.00408	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—CRP—psoriasis	5.09e-05	0.00406	CbGpPWpGaD
Salicylic acid—PTGS2—Overview of nanoparticle effects—IL6—psoriasis	5.06e-05	0.00404	CbGpPWpGaD
Salicylic acid—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	5.06e-05	0.00403	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—CP—psoriasis	5.03e-05	0.00401	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—HLA-E—psoriasis	4.99e-05	0.00398	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—APOE—psoriasis	4.98e-05	0.00397	CbGpPWpGaD
Salicylic acid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.91e-05	0.00392	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—NDUFA5—psoriasis	4.81e-05	0.00384	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—CARM1—psoriasis	4.8e-05	0.00383	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IL4—psoriasis	4.79e-05	0.00382	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	4.7e-05	0.00375	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	4.67e-05	0.00373	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—CP—psoriasis	4.56e-05	0.00363	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—CP—psoriasis	4.47e-05	0.00356	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—psoriasis	4.47e-05	0.00356	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—CARM1—psoriasis	4.35e-05	0.00347	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—CARM1—psoriasis	4.26e-05	0.0034	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—psoriasis	4.15e-05	0.00331	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—CAT—psoriasis	4.14e-05	0.0033	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—CRP—psoriasis	4.14e-05	0.0033	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—CP—psoriasis	4.13e-05	0.0033	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	4.13e-05	0.00329	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—CYP2S1—psoriasis	4.09e-05	0.00326	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—CRP—psoriasis	4.06e-05	0.00324	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.97e-05	0.00317	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—CARM1—psoriasis	3.94e-05	0.00315	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	3.86e-05	0.00308	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.84e-05	0.00307	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—ICAM1—psoriasis	3.8e-05	0.00303	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—ICAM1—psoriasis	3.73e-05	0.00298	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL10—psoriasis	3.73e-05	0.00298	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL4—psoriasis	3.72e-05	0.00297	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL4—psoriasis	3.63e-05	0.0029	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.61e-05	0.00288	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—CARM1—psoriasis	3.58e-05	0.00286	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	3.58e-05	0.00286	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	3.56e-05	0.00284	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—HLA-B—psoriasis	3.55e-05	0.00283	CbGpPWpGaD
Salicylic acid—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	3.55e-05	0.00283	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCL20—psoriasis	3.52e-05	0.00281	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	3.47e-05	0.00277	CbGpPWpGaD
Salicylic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	3.39e-05	0.00271	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.35e-05	0.00267	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	3.31e-05	0.00264	CbGpPWpGaD
Salicylic acid—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	3.31e-05	0.00264	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—HLA-A—psoriasis	3.29e-05	0.00263	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—CRP—psoriasis	3.29e-05	0.00262	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—LEP—psoriasis	3.14e-05	0.00251	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.09e-05	0.00247	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	3.02e-05	0.00241	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	3.01e-05	0.0024	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	2.98e-05	0.00238	CbGpPWpGaD
Salicylic acid—ALB—SLC-mediated transmembrane transport—CP—psoriasis	2.97e-05	0.00237	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	2.96e-05	0.00236	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—ICAM1—psoriasis	2.95e-05	0.00236	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—NOS2—psoriasis	2.93e-05	0.00234	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	2.9e-05	0.00231	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IFNG—psoriasis	2.89e-05	0.00231	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriasis	2.89e-05	0.00231	CbGpPWpGaD
Salicylic acid—PTGS2—C-MYB transcription factor network—CD4—psoriasis	2.85e-05	0.00227	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—IFNG—psoriasis	2.84e-05	0.00227	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	2.77e-05	0.00221	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—NDUFA5—psoriasis	2.52e-05	0.00201	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—NFKB1—psoriasis	2.41e-05	0.00192	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.37e-05	0.00189	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—NFKB1—psoriasis	2.36e-05	0.00189	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.35e-05	0.00188	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	2.32e-05	0.00185	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—TNF—psoriasis	2.3e-05	0.00184	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IFNG—psoriasis	2.3e-05	0.00183	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IFNG—psoriasis	2.25e-05	0.00179	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—CAT—psoriasis	2.2e-05	0.00176	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IFNG—psoriasis	2.2e-05	0.00175	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—NOS2—psoriasis	2.19e-05	0.00175	CbGpPWpGaD
Salicylic acid—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.19e-05	0.00175	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—HLA-A—psoriasis	2.19e-05	0.00175	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP2S1—psoriasis	2.15e-05	0.00171	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	2.09e-05	0.00167	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—APOE—psoriasis	2.04e-05	0.00163	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.04e-05	0.00163	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—NDUFA5—psoriasis	2e-05	0.0016	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—CARM1—psoriasis	2e-05	0.00159	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.99e-05	0.00159	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—SOCS1—psoriasis	1.94e-05	0.00155	CbGpPWpGaD
Salicylic acid—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.91e-05	0.00153	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	1.91e-05	0.00153	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—NOS2—psoriasis	1.9e-05	0.00152	CbGpPWpGaD
Salicylic acid—ALB—Platelet degranulation—VEGFA—psoriasis	1.87e-05	0.0015	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—TNF—psoriasis	1.87e-05	0.00149	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	1.87e-05	0.00149	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.87e-05	0.00149	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—IL6—psoriasis	1.86e-05	0.00148	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	1.84e-05	0.00147	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—ITGAL—psoriasis	1.8e-05	0.00144	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	1.79e-05	0.00142	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—APOE—psoriasis	1.71e-05	0.00137	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP2S1—psoriasis	1.7e-05	0.00136	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.68e-05	0.00134	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.66e-05	0.00132	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—TP53—psoriasis	1.65e-05	0.00132	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—NDUFA5—psoriasis	1.62e-05	0.00129	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—TYK2—psoriasis	1.56e-05	0.00124	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.51e-05	0.00121	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IL6—psoriasis	1.51e-05	0.00121	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—CP—psoriasis	1.51e-05	0.0012	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PPARG—psoriasis	1.49e-05	0.00119	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—TNF—psoriasis	1.49e-05	0.00119	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	1.48e-05	0.00118	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TNF—psoriasis	1.45e-05	0.00116	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	1.44e-05	0.00115	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—LEP—psoriasis	1.43e-05	0.00114	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—APOE—psoriasis	1.43e-05	0.00114	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—TNF—psoriasis	1.42e-05	0.00113	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NDUFA5—psoriasis	1.42e-05	0.00113	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.41e-05	0.00113	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—CD4—psoriasis	1.41e-05	0.00113	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP2S1—psoriasis	1.38e-05	0.0011	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—NFKBIA—psoriasis	1.33e-05	0.00106	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NDUFA5—psoriasis	1.33e-05	0.00106	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.32e-05	0.00105	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.32e-05	0.00105	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TP53—psoriasis	1.28e-05	0.00102	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.27e-05	0.00102	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—VEGFA—psoriasis	1.27e-05	0.00101	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.26e-05	0.00101	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.24e-05	0.000988	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—CAT—psoriasis	1.23e-05	0.00098	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP2S1—psoriasis	1.21e-05	0.000964	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.2e-05	0.000958	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL6—psoriasis	1.17e-05	0.000937	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.15e-05	0.000921	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP2S1—psoriasis	1.13e-05	0.000901	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.13e-05	0.000898	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TYK2—psoriasis	1.09e-05	0.000871	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—STAT3—psoriasis	1.09e-05	0.000871	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CARM1—psoriasis	1.05e-05	0.000837	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.89e-06	0.00079	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.8e-06	0.000782	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TP53—psoriasis	9.59e-06	0.000766	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—APOE—psoriasis	9.54e-06	0.000761	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CXCL8—psoriasis	9.51e-06	0.000759	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	9.37e-06	0.000748	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	9.02e-06	0.00072	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.93e-06	0.000713	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—JUN—psoriasis	8.84e-06	0.000705	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.72e-06	0.000696	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—NFKB1—psoriasis	8.51e-06	0.000679	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CARM1—psoriasis	8.32e-06	0.000664	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	8.31e-06	0.000663	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PPARG—psoriasis	8.31e-06	0.000663	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	8.18e-06	0.000653	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.78e-06	0.000621	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—VEGFA—psoriasis	7.72e-06	0.000616	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—STAT3—psoriasis	7.64e-06	0.00061	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IL6—psoriasis	7.63e-06	0.000609	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—NOS2—psoriasis	7.4e-06	0.00059	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.23e-06	0.000577	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	7.01e-06	0.00056	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CARM1—psoriasis	6.73e-06	0.000537	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CAT—psoriasis	6.45e-06	0.000515	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.29e-06	0.000502	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	6.18e-06	0.000493	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.91e-06	0.000472	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CARM1—psoriasis	5.9e-06	0.000471	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TP53—psoriasis	5.83e-06	0.000466	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CARM1—psoriasis	5.51e-06	0.00044	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL6—psoriasis	5.34e-06	0.000426	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.15e-06	0.000411	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CAT—psoriasis	5.12e-06	0.000409	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HLA-A—psoriasis	5.09e-06	0.000406	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—APOE—psoriasis	5.01e-06	0.0004	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APOE—psoriasis	4.75e-06	0.000379	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NOS2—psoriasis	4.43e-06	0.000353	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PPARG—psoriasis	4.36e-06	0.000348	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VEGFA—psoriasis	4.28e-06	0.000342	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CAT—psoriasis	4.14e-06	0.000331	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—APOE—psoriasis	3.98e-06	0.000317	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CAT—psoriasis	3.63e-06	0.00029	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TYK2—psoriasis	3.63e-06	0.000289	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PPARG—psoriasis	3.46e-06	0.000276	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CAT—psoriasis	3.39e-06	0.000271	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD4—psoriasis	3.28e-06	0.000262	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TP53—psoriasis	3.24e-06	0.000258	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—APOE—psoriasis	3.22e-06	0.000257	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—APOE—psoriasis	2.82e-06	0.000225	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PPARG—psoriasis	2.8e-06	0.000224	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—APOE—psoriasis	2.63e-06	0.00021	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—STAT3—psoriasis	2.54e-06	0.000203	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPARG—psoriasis	2.46e-06	0.000196	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPARG—psoriasis	2.29e-06	0.000183	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6—psoriasis	1.77e-06	0.000141	CbGpPWpGaD
